3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Pain
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Uterine Cervical Dysplasia
1
Papillomavirus Infections
1
Carcinoma in Situ
1
Breast Diseases
1
Agnosia
1
Interventions
entinostat
4
exemestane
3
Trastuzumab
2
Docetaxel
2
Cyclophosphamide
2
ribociclib
1
pembrolizumab
1
pegfilgrastim
1
ipatasertib
1
gadoterate meglumine
1
dactolisib
1
atezolizumab
1
Zoledronic Acid
1
Trabectedin
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Sodium Chloride
1
Paclitaxel
1
Leflunomide
1
Ibuprofen
1
High-Energy Shock Waves
1
Fulvestrant
1
Fentanyl
1
Exercise
1
Everolimus
1
Erlotinib Hydrochloride
1
Educational Status
1
Doxorubicin
1
Codeine
1
Cholecalciferol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Breast Diseases
×
Codeine
×
Clear all
NCT00299039
2009-02-02
T3AI
Nova Scotia Health Authority
Phase 3
Completed
150 enrolled